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Abstract
The cystic fibrosis (CF) airway microbiome is complex; polymicrobial infections are common, and the presence of fastidious
bacteria including anaerobes make culture-based diagnosis challenging. Quantitative real-time PCR (qPCR) offers a culture-
independent method for bacterial quantification that may improve diagnosis of CF airway infections; however, the reliability
of qPCR applied to CF airway specimens is unknown. We sought to determine the reliability of nine specific bacterial qPCR
assays (total bacteria, three typical CF pathogens, and five anaerobes) applied to CF airway specimens. Airway and salivary
specimens from clinically stable pediatric CF subjects were collected. Quantitative PCR assay repeatability was determined
using triplicate reactions. Split-sample measurements were performed to measure variability introduced by DNA extraction.
Results from qPCR were compared to standard microbial culture for Pseudomonas aeruginosa, Staphylococcus aureus, and
Haemophilus influenzae, common pathogens in CF. We obtained 84 sputa, 47 oropharyngeal and 27 salivary specimens from
16 pediatric subjects with CF. Quantitative PCR detected bacterial DNA in over 97% of specimens. All qPCR assays were
highly reproducible at quantities $10
2 rRNA gene copies/reaction with coefficient of variation less than 20% for over 99% of
samples. There was also excellent agreement between samples processed in duplicate. Anaerobic bacteria were highly
prevalent and were detected in mean quantities similar to that of typical CF pathogens. Compared to a composite gold
standard, qPCR and culture had variable sensitivities for detection of P. aeruginosa, S. aureus and H. influenzae from CF
airway samples. By reliably quantifying fastidious airway bacteria, qPCR may improve our understanding of polymicrobial CF
lung infections, progression of lung disease and ultimately improve antimicrobial treatments.
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Introduction
Cystic fibrosis (CF) is a life-shortening, autosomal-recessive
genetic condition. Lung disease characterized by chronic airway
infection and inflammation is the leading cause of morbidity and
mortality in patients with CF [1]. Airway infection is primarily
attributed to a narrow spectrum of bacteria, most commonly
Pseudomonas aeruginosa and Staphylococcus aureus [2,3]. However, CF
airway infections are frequently polymicrobial, and a broad range
of bacteria including anaerobes likely contribute to CF lung
disease [4–6]. In addition, airway cultures may not detect typical
CF associated bacteria even during acute pulmonary exacerba-
tions [7]. Reliance on standard microbial culture methods limits
detection of polymicrobial infections, especially anaerobic bacte-
ria, and the routine use of anaerobic culture is labor-intensive and
unreliable [8]. Thus, the ability to study polymicrobial and
anaerobic infection in CF has been limited.
Molecular detection techniques identify airway bacteria without
reliance on culture [9,10]. Nucleic acid amplification of 16S rRNA
genes specific for the domain Bacteria followed by post-
amplification analyses using terminal restriction fragment length
polymorphism profiling (t-RFLP), Sanger sequencing, or pyrose-
quencing have been used to characterize the bacterial community
in CF airway samples [11–14]. Results from these studies
consistently find a high prevalence of anaerobic bacteria within
a complex polymicrobial community. Quantitative real-time PCR
(qPCR) employs primers specific for particular bacteria to detect
and quantify bacteria without culture [15]. Quantitative PCR is
increasingly used for bacterial identification in conditions such as
sepsis, meningitis, vaginosis and gingivitis [16–20]. Possible
applications of qPCR in CF include rapid detection and
quantification of potentially pathogenic anaerobic bacteria,
assessing response to antimicrobial therapy, and tracking longitu-
dinal changes in airway microbiology in the clinic and in clinical
trials. However, the reliability of qPCR applied to CF airway
specimens, an important step in validating the use of qPCR in CF,
has received little attention, particularly with respect to anaerobic
bacteria.
The goals of this study were to determine the reliability of
bacterial quantification from CF airway samples using qPCR and
to compare qPCR results to standard culture for routinely cultured
CF pathogens. We hypothesized that bacteria, including total
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reproducibly quantified from CF airway samples using qPCR, and
that qPCR would have comparable sensitivity and specificity to
culture for detection of typical CF pathogens. To test this
hypothesis, we applied qPCR to CF airway samples (oropharyn-
geal swab and sputum) to measure total bacteria; three typical CF
pathogens, Pseudomonas aeruginosa, Staphylococcus aureus, and Hae-
mophilus influenzae; and five anaerobic bacteria, Prevotella melanino-
genica, Prevotella oris, Prevotella denticola, Fusobacterium species and
Peptostreptococcus micros. We chose P. aeruginosa, S. aureus, and H.
influenzae as bacterial targets as these are the most common airway
pathogens detected in children with CF [21]. The panel of
anaerobic bacteria was chosen based on preliminary 16S rRNA
sequencing data from our laboratory showing that these bacteria
are frequently present in CF airway samples during pulmonary
exacerbations. Split-sample and triplicate measurements were
performed to determine reproducibility of the qPCR assays.
Salivary samples were also collected and DNA extracted; triplicate
qPCR measurements were performed on the DNA extractions to
determine intra-assay reproducibility. For P. aeruginosa, S. aureus
and H. influenzae, qPCR and culture results were compared to
determine sensitivity, specificity and correlation.
Methods
Ethics Statement
This study was approved by the Colorado Multiple Institutional
Review Board (COMIRB). Written informed consent and HIPPA
Authorization were obtained from all participants over the age of
17 years or from parents or legal guardians of participants younger
than 18 years. Assent was obtained from all participants under 18
years.
Study design
Eligible patients (age 8–21 years) were recruited from the CF
clinic at The Children’s Hospital Denver during routine CF clinic
visits for this prospective study. Patients were identified as potential
participants by the principal investigator and/or research
coordinator prior to clinic visit, and approached by the research
coordinator during the visit to determine patient interest. Inclusion
criteria consisted of (1) a known diagnosis of CF based on sweat
chloride .60 mEq/L or the presence of two known CF mutations
and (2) clinically stable pulmonary disease as defined by clinical
impression and forced expiratory volume in one second (FEV1)
within 15% of baseline. Exclusion criteria consisted of (1)
treatment with oral or intravenous antibiotics (excluding chronic
azithromycin) in the thirty days prior to enrollment, intravenous or
oral corticosteroids in the seven days prior to enrollment or non-
steroidal anti-inflammatory medications in the three days prior to
enrollment, and (2) FEV1 ,40% predicted. Following enrollment,
oropharyngeal, expectorated and induced sputa, and salivary
specimens were collected from subjects at baseline, one month and
one year visits. Oropharyngeal specimens were obtained by
swabbing the posterior pharynx and bilateral tonsillar pillars with
a sterile cotton swab. Prior to sputum collection, salivary
specimens were collected into a sterile specimen cup using a
published method by Navazesh [22]. Spontaneously expectorated
sputum was collected in a sterile specimen cup. Sputum was
induced by inhalation of 3% hypertonic saline as previously
described [23].
Standard CF bacterial culture
The clinical microbiology laboratory processed all airway
specimens following standardized CF airway culture guidelines
[2]. Oropharyngeal swabs were emulsified in 1 ml sterile saline.
Sputa specimens were homogenized with 1% dithiothreitol
(Calbiochem, Los Angeles, CA) in the presence of glass beads,
and diluted with sterile saline (1:10). Aliquots of each specimen
were plated onto the following culture media: blood agar,
MacConkey agar, Haemophilus isolation agar (HAE), Burkholderia
cepacia selective agar (Remel Products, Lenexa, KS) and mannitol
salt agar (MAN). Oropharyngeal culture results were semi-
quantitative based on culture plate growth (range 1+ to 4+).
Pseudomonas aeruginosa and other gram negative bacteria identified
by sputum culture were reported and quantified if present in
quantities $10
3 colony-forming units (cfu) per milliliter. Staphylo-
coccus aureus and H. influenzae colony counts were estimated from
HAE and MAN plates. Burkholderia cepacia species identification
was qualitative. Remaining specimen aliquots were frozen at 270
degrees Celsius for molecular studies. Salivary specimens were
directly frozen without processing or culture at 270 degrees
Celsius.
Processing for molecular studies
Frozen oropharyngeal, sputa, and saliva specimens were thawed
on ice. In order to examine variability in our DNA extraction
process, split samples of oropharyngeal and sputa specimens were
prepared and molecular analyses were run in parallel on the
duplicate DNAs. Salivary specimens were not split, thus a single
DNA extraction was performed. DNA was extracted from each
sample directly using a modified bead beating and solvent
extraction protocol [12]. Each sample was combined with 500 ml
of 2x buffer B (143 mM Tris pH 8.0, 143 mM NaCl, 14 mM
EDTA and 5.7% SDS), 500 ml phenol:chloroform, and approx-
imately 0.25 g zirconium beads (0.1 mm, Biospec Products Inc.).
The mixture was then mechanically disrupted by reciprocation for
two minutes using an eight-channel bead beater (Biospec Products,
Inc). Samples were centrifuged (16,0006g) for three minutes to
separate the aqueous and organic phases. The DNA from 400 ml
of the supernatant was precipitated using 7.5 M ammonium
acetate (160 ml) and isoproponol (560 ml). This mixture was then
centrifuged (16,0006g) for twenty minutes and decanted. The
DNA pellet was washed with 1 ml of 70% ethanol and centrifuged
for 5 minutes to ensure recovery of the DNA pellet. The DNA
pellet was air dried, and re-suspended in 50 ml of TE (10 mM Tris
pH 8.0, 1 mM EDTA). All extractions included a negative
extraction control where buffer only was extracted in parallel
with specimens. The precipitated DNA was used directly in qPCR
reactions without further purification.
Quantitative real-time PCR (qPCR)
Bacterial quantification was performed on DNA extracts using
qPCR assays designed to measure (1) all bacteria, referred to as
bacterial load assay [24] and (2) specific organisms, referred to as
specific organism assays. Specific organism assays were performed for
the following bacteria: P. aeruginosa, S. aureus, H. influenzae, Prevotella
melaninogenica, P. oris, P. denticola, Fusobacterium species, and Pep-
tostreptococcus micros [25–27]. All assays were performed by one of
two technicians, trained in molecular diagnostics and blinded to
the culture results. All qPCR assays were run in triplicate, and two
negative PCR controls were run on each sample plate. All assays
except for H. influenzae were based on previously published assays.
The results are presented following Standards for Reporting of
Diagnostic Accuracy (STARD) guidelines [28].
For H. influenzae, primers were designed from our in-house
database containing hundreds of sequences obtained from CF
airway specimens for H. influenzae with a product size of ,600 base
pairs. During development of the H. influenzae assay, we directly
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were positive for H. influenzae by qPCR. All amplicons were
consistent with H. influenzae with $99% sequence identity
(MegaBACE 1000 DNA Analysis System, GE Healthcare,
Amerisham). To examine the specificity of our assay, we
performed cross-reactivity studies by applying our qPCR assay
to a three-fold dilution series (10
4–10
6) with two H. influenzae
strains (ATCC49247 and ATCC10211) and three H. parainfluenzae
strains (ATCC7901 and 2 patient strains from the clinical
microbiology laboratory at The Children’s Hospital Denver). In
addition, three dilutions (10
4–10
6) with equal mixtures by weight
of DNA from the two bacterial species and one 1:100 H. influenzae:
H. parainflenzae DNA mixture were analyzed with our H. influenzae
qPCR assay. Results of qPCR were compared to the known
amount of target bacterial DNA in each mixture.
Bacterial load assay. Total ribosomal RNA gene copy
number was measured using a quantitative PCR (qPCR)
TaqMAN assay (Roche Molecular Systems, Inc.), as described
by Nadkarni and co-workers [24]. A cloned bacterial rRNA gene
(P. melaninogenica) was used as the standard ranging in dilution from
10
2 to 10
8 copies on each plate. A clone with one 16S rRNA
operon was used due to difficulty obtaining a precise copy number
from genomic DNA and the predominance of slow-growing
bacterium in CF airway samples [29,30].
Specific organism assays. The qPCR reactions were run
using the Power SYBRH Green PCR Master Mix (Applied
Biosystems) and the appropriate PCR primers. Bacterial standards
ranging in dilution from 10
2 to 10
8 copies were run on each plate.
Melting temperature (Tm) was measured for each qPCR reaction.
If the measured Tm was outside the prespecified range
(determined from the standards) for each specific organism then
the resulting copy number was considered not detected. Resulting
values (Raw value, DNA copies/reaction) were log10 transformed.
To confirm that the correct amplicon size was obtained, standards
and reactions were analyzed by agarose gel electrophoresis.
Cross-reactivity studies were performed for P. denticola, P. oris
and P. melaninogenica to insure specificity of the primers.
Fusobacterium spp. was included as a control. Equal mixtures of
the four bacteria of interest were created to total quantities ranging
from 10
2 to 10
8 copies. Samples with Fusobacterium spp. standards
were included on each plate. The assays for P. denticola, P. oris and
P. melaninogenica were performed, and qPCR results were
compared to the known amount of target bacterial DNA in each
mixture.
Between-plate and within-plate studies were performed on a
subgroup of airway specimens to measure precision and quantify
sources of variability in the qPCR assays. Quantitative PCR assays
for bacterial load and P. melaninogenica were performed on samples
run on each of three plates and randomly assigned to three wells
within a plate (9 replicates per sample).
Quality Control Matrix
Results from all qPCR reactions were assessed using a quality
control matrix designed to manage missing values and to identify
unreliable results for repeat analysis. Coefficient of variation (CV)
was calculated for each set of triplicate reactions. Results were
considered consistent if all three values were not-detected, or if (1)
all three replicates had detectable DNA, (2) the CV was less than
20%, and (3) the median value was less than 9. The upper limit of
10
9 was set to identify any reaction with copy numbers outside the
range of the standard curve. For samples with consistent results,
the mean value of the three replicates was taken to represent the
copies of bacterial rRNA genes present in the sample. If all three
replicates were not-detected, then the quantity of bacteria present
was assumed to be below the limit of detection. Inconsistent results
were examined in more detail and in most cases the result was
determined using a set of quality control rules developed by the
authors. The following is an overview of those rules: (1) if two
values were not-detected and the third value was ,10 copies/
reaction, then the sample value equaled the detected value, and (2)
if two non-missing values were within 0.2 log, with the third value
being either missing or different by more than 0.2 log, then the
sample value equaled the mean of two values. Assays that did not
meet these criteria were considered unacceptable and qPCR
reactions were rerun. A more complete description of the specific
quality control rules is provided in the supporting data (Figure S1).
Statistical Analysis
Descriptive statistics include the mean and standard deviation
or the median and 5
th and 95
th percentiles, where specified. The
limit of detection for each assay was calculated as the mean plus
three times the standard deviation of the measurement from
negative controls. Paired t-tests were used to evaluate whether the
split sample runs (B versus C) were significantly different. P-values
,0.05 were considered statistically significant. Bland-Altman plots
were used to visualize the agreement between split-sample runs.
Additionally, comparisons between split sample measures were
performed by categorizing whether or not the organism was
present and calculating agreement between the two measure-
ments. In order to examine our data for the secondary analysis,
where random wells were assigned to standards and unknowns, we
used a classical ANOVA model to explain the variation in the log-
transformed data in terms of five factors (well, plate, duplicate,
sample type and subject) and pairwise interactions within all the
factors with exception of the well variable. Comparisons between
two median values were performed using two-sample median tests.
In order to determine the sensitivity of qPCR and culture for
qualitative detection of standard CF pathogens (P. aeruginosa, S.
aureus and H. influenzae), we created a composite ‘‘gold-standard’’
result. If either culture or qPCR was positive, then the composite
result was positive. We then compared qPCR and culture to the
composite results to determine their sensitivity. Specificity of
qPCR was determined by comparing detection by qPCR using
culture as the gold-standard. A non-parametric Spearman’s rank
correlation coefficient was assessed between the culture and qPCR
measurements to compare quantitative results. All analyses were
performed using SAS version 9.2 software (SAS Institute Inc.:
Cary, NC, 2008).
Results
Specimens Collected
Eighteen CF subjects were enrolled between July 2006 and
September 2007; the final study visit was completed in September
2008. Two subjects were withdrawn from the study due to the
presence of pulmonary symptoms at the baseline visit. We
collected 159 specimens from 16 subjects at three visits over one
year consisting of 47 oropharyngeal swabs, 38 expectorated sputa,
47 induced sputa, and 27 saliva specimens. Subject characteristics
at their baseline visit are shown in Table 1. No adverse events
occurred during the study. Culture results were not obtained on
saliva samples and in some cases specimens had inadequate
quantities for both qPCR and culture. Seven specimens (six
oropharyngeal and one expectorated sputum) underwent culture
but not molecular analysis. Three specimens (one each of
expectorated sputum, induced sputum and oropharyngeal swab)
were analyzed only with molecular methods, resulting in 129
specimens with culture results, 152 specimens with qPCR results,
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collection, processing and analysis are shown in Figure 1.
Standard bacterial culture
The following bacteria were detected by standard CF bacterial
culture from oropharyngeal and sputa specimens (n=129
specimens): S. aureus (n=81, 63%), P. aeruginosa (n=58, 45%),
Streptococcus milleri group (n=26, 20%), H. influenzae (n=17, 13%),
S. maltophilia (n=14, 11%) and A. xylosoxidans, (n=10, 8%). Other
bacteria detected infrequently consisted of: Acinetobacter spp. (n=2),
Pseudomonas fluorescens (n=1), and Streptococcus pyogenes (n=1).
Burkholderia cepacia complex species were not detected from any
specimen during the study.
Quantitative real-time PCR
Split sample aliquots (referred to as B and C) from 125
oropharyngeal and sputa specimens were extracted in parallel and
27 saliva samples were extracted singly for a total of 277 DNA
samples analyzed by qPCR (n=2,493 sample measurements). For
the bacterial load assay, bacterial rRNA genes were present in
quantities $10
2 copies/reaction in 97% of specimens including
98% of sputa, 95% of oropharyngeal and 100% of salivary
specimens. For those samples with at least 100 copies of rRNA
genes detected, the median quantity (log10 scale) was 4.9 copies/
reaction (range 3.4–6.3). Results from all qPCR assays are shown
in Table 2. Anaerobes were highly prevalent from all sample types
with detection rates ranging from 20% (P. oris) to 73% (P.
melaninogenica). When detected, anaerobes were present in
quantities similar to that of CF-associated pathogens. The limits
of detection for qPCR assays were as follows: bacterial load assay
(n=38 negative controls), 87 copies/reaction; P. melaninogenica
(n=28 controls), 5.1 copies/reaction; H. influenzae (n=28
controls), 8.1 copies/reaction; and, P. micros (n=30 controls),
38.7 copies/reaction. For all other assays, there were no DNA
copies detected in any of the negative controls; thus, we could not
calculate a limit of detection.
H. influenzae cross-reactivity studies
We examined DNA consensus data for close relatives of H.
influenzae (Table S1). Our H. influenzae qPCR assay was applied to
DNA samples from two ATCC strains of H. influenzae and three
ATCC strains of H. parainfluenzae. After excluding copies amplified
outside the Tm range set by the standard (8762), there was no
detectable bacterial DNA amplified in three-fold dilutions of H.
parainfluenzae (n=27 reactions). Both strains of H. influenzae
amplified as expected with Tm ranging from 86–87 (n=12
reactions). In mixture studies with a 1:1 ratio by weight of DNA
(n=27 reactions), there was evidence of some cross-reactivity with
mean amount of target bacterial DNA detected of 160% (range
107–268%). However, in mixture studies with 1:100 ratio of H.
influenzae to H. parainfluenzae (n=9 reactions), the mean amount of
target bacteria detected was 118% (range 98–140%) suggesting
low levels of amplification of H. parainfluenzae (Tables S2 and S3).
Reliability of qPCR
For all assays, we compared the coefficient of variation (CV),
calculated across the triplicates, to the average quantity (log10
copies per reaction) detected in each sample. Results for the
bacterial load assay and specific organism assays are shown in
Figures 2a and 2b, respectively. For samples with $2 log10 copies/
reaction, all assays were highly reproducible with CV ,20% for
greater than 99% of samples. There was no difference in the
repeatability of our assays by specimen type (oropharyngeal
compared to sputum or saliva) or by specific organism assay.
There was also no difference in repeatability between expectorated
and induced sputum; thus, results from all sputa specimens are
presented together. To confirm amplification of the correct PCR
product, gel electrophoresis was performed, which confirmed that
a single product was amplified.
Comparison of split-samples
We compared the B and C duplicates from oropharyngeal and
sputa specimens (n=125 DNA samples, 1125 sample measure-
ments). The average difference between the duplicate runs was
20.02 log10 copies/reaction (95% CI: 20.06 – 0.03). There were
no significant differences between duplicates when examined by
assay and specimen type. There was 91% agreement between runs
for all assays. By assay type, the agreement was as follows, bacterial
load assay, 97%; P. aeruginosa, 92%; S. aureus, 93%; H. influenzae,
89%; P. melaninogenica, 94%; P. oris, 90%; P. denticola, 85%;
Fusobacterium spp., 91%; and, P. micros, 86%. Bland-Altman plots
are shown in Figures 3a and 3b which display the difference
between the duplicate extractions versus the average for the
bacterial load assay and specific organism assays respectively. The
majority of points are evenly scattered near the line indicating a
difference of zero, or equivalence. The median value of those
samples that did not agree (bacteria present in one duplicate but
not detected in the other) was 1.2 log10 copies/reaction (5
th–95
th
percentile range, 0.3–3.5) compared to 2.9 log10 copies/reaction
(5
th–95
th percentile range, 0.8–5.3) for those that did agree,
indicating that the samples that did not agree had a lower values
compared to those that did agree (p,0.01).
Total precision and Prevotella cross-reactivity studies
Between-plate and within-plate studies were performed on 12
specimens consisting of eight sputa, two oropharyngeal, and four
salivary specimens from four subjects. The sputa and oropharyn-
geal specimens were divided into B and C split-samples; thus, 24
DNA samples were analyzed. Each of the 24 samples was
measured on each of three plates and was randomly assigned to
three wells within a plate. Bacterial load and P. melaninogenica assays
were performed on all samples (n=432 sample measurements).
The single largest source of variation was attributable to subject
effects; this term provided by far the largest F-test value in the
Table 1. Baseline subject characteristics (N=16).
Characteristic Value
Age, years, median (range) 13 (8–20)
Male gender, n (%) 10 (63)
Race
Caucasian, n (%) 15 (94)
African-American, n (%) 1 (6)
Genotype
F508del homozygous 7 (44)
F508del heterozygous 6 (38)
FEV1, percent predicted, median (range) 96 (58–133)
No. of specimens per patient, median (range) 10 (8–12)
Culture results from induced sputum, n (%)
Pseudomonas aeruginosa 8 (50)
Staphylococcus aureus 9 (56)
Haemophilus influenzae 4 (25)
doi:10.1371/journal.pone.0015101.t001
Detection of Airway Bacteria in Cystic Fibrosis
PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e15101ANOVA. The lowest source of variability was between wells on a
plate followed by plate-to-plate variability (Figure S2). There was
less variability between subjects and specimen type in the all
bacteria assay compared to the P. melaninogenica assay.
We performed cross-reactivity studies for P. melaninogenica, P. oris,
and P. denticola assays. Between 10
3 and 10
7 copies, there was no
evidence of cross-reactivity for any of the Prevotella qPCR assays
with a mean amount of target bacteria detected of 91% (range,
73–113%) of the expected copy number. At the limits of the
standard curve, 10
2 and 10
8 copies, there was evidence of cross-
reactivity with a mean amount of target bacteria detected of 211%
(range, 193–222%) (Table S4). For the Fusobacterium spp.
standards, there was no bacterial DNA detected by any of the
Prevotella assays.
Quality Control Matrix
Overall, consistent results by triplicate qPCR assays were
obtained for 82.9% of DNA sample measurements (n=2,067/
2,493) including 31.3% of sample measurements that had no
target bacterial DNA detected (n=780). Using our quality control
(QC) rules, we determined a value for 11.2% of remaining sample
measurements (n=279), and only 5.9% of sample measurements
(n=147) were rerun. The majority of sample measurements
identified as inconsistent had final values less than 100 copies/
reaction (n=324 of 427, 76%), suggesting more assay variability at
low quantities.
The subset of 427 sample measurements (17.1%) that were
considered inconsistent but assigned values either by the QC rules
or after re-running the assay were used to compare the results of
using the QC rules versus simply averaging the three triplicate
values. The majority of sample measurements (n=272 of 427,
64%) were assigned equivalent values using either the QC rules or
simply averaging. There were 134 sputa or oropharyngeal
specimens where at least one of the duplicate extractions was
considered inconsistent and where the final values assigned
differed across the two approaches. There was no striking
improvement in the comparison of the duplicate extractions using
the QC rules when looking across all samples; however, for those
samples where the difference between the duplicates was $10
2
copies/reaction (n=25 sample measurements), the use of the QC
Figure 1. Specimen collection, processing, and quality control algorithm. Expectorated and induced sputa, oropharyngeal swabs and
salivary specimens were collected and processed for standard CF microbial culture and/or DNA extraction (split-samples performed for sputa and
oropharyngeal specimens). Bacterial load qPCR assay and eight specific organism qPCR assays were run in triplicate on all samples. Results were
assessed using a quality control matrix and final value assigned to each sample. ES = expectorated sputum, IS = induced sputum, OP =
oropharyngeal swab.
doi:10.1371/journal.pone.0015101.g001
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samples in 60% of sample measurements (n=15) compared to
simply averaging the triplicate values.
Comparison of qPCR and microbial culture
We compared results from qPCR with microbial culture for P.
aeruginosa, S. aureus and H. influenzae. For sputa specimens, culture
and qPCR results were congruent in 90% for P. aeruginosa, 78% for
S. aureus, and 54% for H. influenzae. For oropharyngeal swab
samples, culture and qPCR results were congruent in 75% for P.
aeruginosa, 35% for S. aureus, and 75% for H. influenzae. Among all
sample types, discordant results consisted of 10 culture positive/
qPCR negative and 8 qPCR positive/culture negative for P.
aeruginosa, 43 culture positive/qPCR negative and 1 qPCR
positive/culture negative for S. aureus, and 6 culture positive/
qPCR negative and 42 qPCR positive/culture negative for H.
influenzae. (Table 3) For S. aureus, we examined the quantity
detected by quantitative culture for sputa specimens with
discordant results. For those that were detected in culture, the
median quantity in the samples missed by qPCR was
Table 2. Results from quantitative PCR assays.
qPCR assay (n=
277 samples)
Sample
Type
Samples with
mean $10
2
copies/reaction,
n( % )
Bacterial
DNA not
detected,
n( % )
Acceptable
value
obtained
after QC,
n( % )
Samples
rerun,
n( % )
Median (5
th–95
th
percentile) log10
[copies/reaction]
for samples with
$10
2 copies/reaction
CV for samples with
$10
2 copies/reaction,
median (5
th–95
th
percentile)
Bacterial Load All 269 (97) 7 (3) 273 (99) 4 (1) 4.9 (3.4 – 6.3) 2.1 (0.4 – 12.5)
Sputum 164 (98) 4(2) 168 (100) 0 (0) 4.8 (3.4 – 6.1) 2.2 (0.5 – 9.8)
OP 78 (95) 3 (4) 80 (98) 2 (2) 4.7 (3.1 – 5.7) 2.3 (0.4 – 13.2)
Saliva 27 (100) 0 (0) 25 (93) 2 (7) 5.3 (4.1 – 6.6) 1.8 (0.4 – 17.0)
P. aeruginosa All 63 (23) 161 (58) 269 (97) 8 (3) 3.2 (2.1 – 5.7) 2.9 (0.5 – 9.8)
Sputum 56 (33) 81 (48) 162 (96) 6 (4) 3.2 (2.1 – 5.9) 2.9 (0.4 – 10.2)
OP 3 (4) 61 (74) 80 (98) 2 (2) 3.3 (2.1 – 3.4) 3.3 (2.6 – 9.8)
Saliva 4 (15) 19 (70) 27 (100) 0 (0) 2.9 (2.0 – 3.8) 4.6 (0.6 – 6.4)
S. aureus All 62 (22) 192 (69) 265 (96) 12 (4) 3.4 (2.4 – 4.7) 5.4 (1.8 – 18.3)
Sputum 55 (33) 102 (61) 160 (95) 8 (5) 3.4 (2.4 – 4.7) 5.3 (1.8 – 18.3)
OP 1 (1) 74 (90) 79 (96) 3 (4) 2.2 8.6
Saliva 6 (22) 16 (59) 26 (96) 1 (4) 2.9 (2.4 – 4.7) 5.5 (2.1 – 10.4)
H. influenzae All 100 (36) 143 (52) 239 (86) 38 (14) 3.3 (2.3 – 4.2) 1.8 (0.3 – 7.3)
Sputum 75 (45) 74 (44) 142 (85) 26 (15) 3.4 (2.3 – 4.3) 1.8 (0.3 – 7.3)
OP 18 (22) 52 (63) 75 (92) 7 (9) 2.9 (2.7 – 3.5) 1.5 (0.1 – 7.0)
Saliva 7 (26) 17 (63) 22 (82) 5 (19) 3.4 (2.3 – 3.6) 3.5 (1.0 – 15.7)
P. melaninogenica All 203 (73) 12 (4) 268 (97) 9 (3) 3.2 (2.1 – 4.8) 2.9 (0.7 – 11.2)
Sputum 122 (73) 5 (3) 162 (96) 6 (4) 3.3 (2.1 – 4.6) 3.4 (0.6 – 10.7)
OP 60 (73) 6 (7) 80 (98) 2 (2) 2.9 (2.1 – 4.4) 2.9 (0.8 – 11.4)
Saliva 21 (78) 1 (4) 26 (96) 1 (4) 4.0 (2.8 – 5.6) 1.7 (1.0 – 8.0)
P. denticola All 72 (26) 89 (32) 266 (96) 11 (4) 2.8 (2.1 – 3.8) 3.8 (0.9 – 14.3)
Sputum 44 (26) 61 (36) 162 (96) 6 (4) 2.9 (2.1 – 3.8) 3.4 (0.9 – 9.5)
OP 13 (16) 22 (27) 77 (94) 5 (6) 2.6 (2.0 – 3.5) 5.7 (1.8 – 32.9)
Saliva 15 (56) 6 (22) 27 (100) 0 (0) 2.7 (2.1 – 4.3) 2.4 (0.5 – 9.3)
P. oris All 56 (20) 77 (28) 270 (98) 7 (3) 2.7 (2.1 – 4.2) 3.6 (0.6 – 15.3)
Sputum 36 (21) 43 (26) 163 (96) 5 (3) 2.8 (2.1 – 4.2) 3.7 (0.6 – 16.2)
OP 8 (10) 27 (33) 81 (99) 1 (1) 2.7 (2.2 – 2.9) 2.9 (0.8 – 14.0)
Saliva 12 (44) 7 (26) 26 (96) 1 (4) 2.9 (2.0 – 4.0) 3.3 (0.4 – 6.3)
F. nucleatum All 114 (41) 77 (28) 264 (95) 13 (5) 2.7 (2.1 – 4.1) 2.7 (0.6 – 7.6)
Sputum 74 (44) 48 (29) 161 (96) 7 (4) 2.7 (2.0 – 4.0) 2.6 (0.6 – 7.6)
OP 25 (30) 21 (26) 76 (93) 6 (7) 2.5 (2.1 – 4.1) 3.2 (0.7 – 9.7)
Saliva 15 (56) 8 (30) 27 (100) 0 (0) 3.4 (2.2 – 5.0) 2.1 (0.3 – 6.0)
P. micros All 183 (66) 21 (8) 232 (84) 45 (16) 3.0 (2.1 – 4.4) 3.4 (0.7 – 16.9)
Sputum 107 (64) 9 (5) 133 (79) 35 (21) 3.1 (2.1 – 4.7) 3.1 (0.7 – 16.9)
OP 52 (63) 11 (13) 75 (92) 7 (9) 2.9 (2.1 – 3.7) 4.7 (0.8 – 15.8)
Saliva 24 (89) 1 (4) 24 (89) 3 (11) 3.3 (2.2 – 4.4) 2.7 (0.9 – 19.7)
OP = Oropharyngeal swab; QC = quality control; CV = Coefficient of variation.
doi:10.1371/journal.pone.0015101.t002
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3 cfu/ml (IQR, 2.0610
3 – 7.9610
4) which was lower than
for those detected by qPCR [4.0610
6 cfu/ml (IQR, 1.0610
5–
2.0610
7), p,0.01].
The sensitivity of qPCR assays and culture compared to the
composite gold standards are shown in Figure 4. Culture and
qPCR had similar sensitivities for detection of P. aeruginosa from
sputum, but qPCR was less sensitive from oropharyngeal swabs.
Culture was more sensitive for S. aureus, especially from
oropharyngeal swabs, and less sensitive for H. influenzae compared
to qPCR. Using culture as the gold standard, the sensitivity and
specificity of qPCR was generally higher in sputum samples versus
throat swab and was best for P. aeruginosa. The correlation between
quantitative culture and qPCR for sputa samples (n=82) for P.
aeruginosa was 0.82 (p,0.01), for S. aureus was 0.63 (p,0.01) and for
H. influenzae was 0.23 (p,0.04). To further examine the low
sensitivity of the S. aureus qPCR assay, we determined the
sensitivity of qPCR compared to culture relative to quantitative
culture results. For specimens with S. aureus present in quantities
between 10
3–10
5 cfu/ml by culture (n=18), the sensitivity of
qPCR was 22%. For specimens with S. aureus present in quantities
.10
5 cfu/ml by culture (n=31), the sensitivity of qPCR was 87%.
(Figure S3)
Discussion
Our results indicate that bacterial DNA, including all bacteria,
typical CF pathogens, and anaerobic bacteria, can be reproducibly
quantified from CF airway specimens using qPCR. The bacterial
load assay and specific organism assays had high intra-assay
repeatability for specimens with rRNA gene copy numbers $10
2.
In addition, qPCR results for split samples had excellent
agreement for bacterial DNA detection and quantification
indicating that little variability was introduced by our DNA
extraction technique. Results from between-plate and within-plate
analyses also indicate that variability in sample measurements was
primarily attributable to subject and specimen differences and that
processing variability was negligible. Anaerobes were detected
frequently by qPCR from all airway specimen types.
Our results also indicate that the qPCR assays for P. aeruginosa,
S. aureus and H. influenzae have variable sensitivity compared to
culture for bacterial detection from CF airway specimens.
Quantitative PCR and culture had similar sensitivity for detection
of P. aeruginosa from sputa, but qPCR was less sensitive for
detection of P. aeruginosa from oropharyngeal specimens. Staphylo-
coccus aureus was detected less frequently by qPCR, particularly
from oropharyngeal swabs and from sputum specimens with low
quantities of S. aureus by quantitative culture (,10
5 cfu/ml). The
increased sensitivity from sputum, especially for specimens with
higher bacterial counts, and the high agreement between split-
samples despite overall low sensitivity suggests that the limitation
of qPCR is related to specimen characteristics, particularly low
quantities of bacterial DNA, rather than inconsistency in assay
performance. Unlike P. aeruginosa and S. aureus, H. influenzae was
Figure 2. Relationship between qPCR reproducibility and
quantity of bacterial DNA detected. Coefficient of Variation (CV)
versus mean value of bacterial DNA (log10 copies/reaction) detected in
triplicate reactions for each DNA sample measurement for (a) bacterial
load assay, n=277 sample measurements, and (b) specific organism
assays, n=2216 sample measurements.
doi:10.1371/journal.pone.0015101.g002
Figure 3. Comparison of qPCR assay results for split-sample
measurements. Bland-Altman plots comparing split-sample measure-
ments for (a) bacterial load assay (n=125 paired sample measure-
ments), and (b) specific organism assays (n=1000 paired sample
measurements). The straight lines indicate specimens with gene copies
detected in one sample and not in the other matched pair.
doi:10.1371/journal.pone.0015101.g003
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types.
The ability to reproducibly quantify anaerobic bacteria from CF
airway samples is an important advance in studying the complex
CF airway microbiome. Two important developments sparked
recent interest in anaerobic infection in CF. First, Worlitzsch and
co-workers demonstrated that P. aeruginosa was found in hypoxic
mucus plugs within the CF airway lumen in patients with
chronically infected with P. aeruginosa [6]. Second was the
development of molecular techniques that allow detection of
fastidious bacteria including anaerobic bacteria without the need
for culture [9,31,32]. Multiple studies using molecular techniques
or strict anoxic culture have demonstrated anaerobic bacteria in
CF airway samples, including during pulmonary exacerbations
[4,5,12,14,33,34]. Studies using molecular detection have relied
primarily on PCR amplification with universal bacterial primers
followed by terminal restriction fragment length polymorphism (t-
RFLP) analysis or sequencing. These methods provide an
important overview of the microbial community present in each
sample. Unlike microbial community analysis, qPCR allows
quantification of specific bacteria of interest. Potential applications
of qPCR to CF include rapid detection and quantification of
potentially pathogenic anaerobic bacteria, assessment of response
to antimicrobial therapy, and tracking longitudinal changes in
airway microbiology.
There are several potential limitations to our study and the use
of qPCR in CF. As oropharyngeal swabs are the primary means of
non-invasive bacterial surveillance in young children with CF, the
low sensitivity of these qPCR assays for P. aeruginosa and S. aureus
may limit the utility of qPCR in this population [35]. Unlike our
findings, Matsuda and co-workers reported excellent sensitivity of
qPCR compared to culture for detection of these bacteria from
blood specimens using these primers. There are several possible
explanations for our lower sensitivity. CF sputum is highly
tenacious and typically contains a large amount of inflammatory
cells, primarily neutrophils resulting in release of large amounts of
human DNA which may interfere with qPCR detection of
relatively small quantities of bacterial DNA[36]. Second, S. aureus
bacterium may not have been sufficiently lysed by our processing
methods. However, specimens were processed twice with bead-
beating techniques prior to qPCR so help ensure adequate lysis.
Also, there was excellent agreement between parallel DNA
extractions suggesting that lysis was at least consistent between
samples. Third, bacterial DNA may have been present below the
level of detection for qPCR. To investigate this further, we
determined the sensitivity of qPCR relative to quantitative culture
results and found significantly higher sensitivity in specimens with
$10
5 cfu/ml. As oropharyngeal swabs may have lower quantities
of bacterial DNA than sputa samples, the finding of lower
sensitivity for oropharyngeal specimens for both P. aeruginosa and S.
aureus supports this explanation. Finally, the growth phase of
bacteria or the presence of biofilms also may impact the quantity
and detection of rRNA genes [25,29,37].
Another limitation to our study was the lack of anaerobic
culture with which to compare our qPCR assays for anaerobic
bacteria. Anaerobic cultures of airway samples are problematic in
that they are labor intensive, outside standard practice for most
clinical microbiologic laboratories and may have variable
performance; thus, their utility as a gold-standard comparison is
limited. To address this concern, we analyzed our qPCR products
using gel electrophoresis to identify side products that may have
interfered with our results and performed cross-reactivity studies
for the Prevotella assays. We found minimal cross-reactivity among
Prevotella species except at extreme low and high levels of bacterial
DNA. The qPCR assays used for P. micros and Fusobacterium are
published assays that have been shown to have good agreement
Table 3. Cross-tabulation of qPCR and standard microbial culture results for typical CF pathogens (N=122 airway specimens
consisting of 82 sputa and 40 oropharyngeal specimens).
qPCR Negative/Culture
Negative
qPCR Negative/Culture
Positive
qPCR Positive/Culture
Negative
qPCR Positive/Culture
Positive
P. aeruginosa 58 10 8 46
Sputum 36 2 6 38
Oropharyngeal 22 8 2 8
S. aureus 42 43 1 36
Sputum 32 18 0 32
Oropharyngeal 10 25 1 4
H. influenzae 63 6 42 11
Sputum 36 4 34 8
Oropharyngeal 27 2 8 3
doi:10.1371/journal.pone.0015101.t003
Figure 4. Sensitivity of qPCR and culture compared to a
composite gold-standard for P. aeruginosa, S. aureus, and H.
influenzae. (N=122 specimens) ES= expectorated sputum, IS=
induced sputum, OP= oropharyngeal swab.
doi:10.1371/journal.pone.0015101.g004
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cross-reactivity with other bacterial species [27].
Unlike our findings with S. aureus and P. aeruginosa, qPCR
appears more sensitive than culture for detection of H. influenzae.
Dithiothreitol, used for sputum homogenization as recommended
in CF airway culture guidelines, has been shown to inhibit the
growth of H. influenzae in culture [2,38]. Although the use of
dithiothreitol may in part explain the low sensitivity of sputum
culture compared with qPCR, oropharyngeal specimens not
processed with dithiothreitol also had a low detection rate of H.
influenzae by culture. In findings similar to our results, Van Belkum
and colleagues detected H. influenzae from 4 of 6 CF untreated
sputa samples by PCR but not by culture using PCR amplification
of bacterial small subunit rDNA followed by probe mediated
bacterial identification [39]. Thus, PCR may be more sensitive
than culture for H. influenzae. To examine the specificity of the
qPCR assay for H. influenzae, sequencing was performed on a sub-
group of assays. The amplified PCR product was confirmed as H.
influenzae with $99% sequence identity. We found some cross-
reactivity between H. influenzae and H. parainfluenzae in mixed
reactions, but in the absence of H. influenzae, there was no
amplification of H. parainfluenzae within the Tm range determined
by standards.
We also explored the use of a quality control matrix designed to
manage missing values and to identify unreliable results for repeat
analysis. Overall, less than 1% of sample measurements had
improved agreement between split-sample measurements with the
application of our QC matrix. For the large majority of our
samples, simple averaging of triplicate measurements (with missing
values set to not-detected) resulted in equivalent values and
agreement between split-samples as our results with the applica-
tion of QC.
In conclusion, we found that qPCR is a reproducible method
for detection of bacteria including anaerobic bacteria from CF
airway samples. Using qPCR, anaerobes were detected frequently
from CF airway specimens, in quantities similar to that of typical
CF associated pathogens. The sensitivity of our qPCR assays for
detection of P. aeruginosa and S. aureus, especially from oropharyn-
geal specimens may limit its usefulness for detection of these
pathogens. Refinement of these qPCR assays, including the use of
alternative primers, may help address this limitation. The
application of qPCR to airway specimens may improve our
understanding of the clinical importance of polymicrobial infection
and anaerobic bacteria, progression of lung disease and ultimately
improve antimicrobial treatments in CF.
Supporting Information
Table S1 Comparison of DNA priming sites for H.
influenzae and selected relatives.
(PDF)
Table S2 H. influenzae qPCR assay specificity studies.
(DOC)
Table S3 H. influenzae cross-reactivity studies.
(DOC)
Table S4 Prevotella cross-reactivity data. Equal mixtures
of P. melanogenica, P. oris, P. denticola and F. nucleatum were analyzed
with qPCR assays for Prevotella spp.. Fusobacterium nucleatum
standards were run on all plates.
(XLS)
Figure S1 Quality control matrix with decision tree for
samples with inconsistent results. There were 2,493 sample
measurements (277 DNA samples x 9 qPCR assays) performed in
triplicate. Coefficient of variation (CV) was calculated for each set
of triplicate reactions. Results were considered consistent if all
three values were not-detected, or if (1) all three replicates had
detectable DNA, (2) the CV was less than 20%, and (3) the median
value was less than 9. The upper limit of 10
9 was set to identify any
reaction with copy numbers outside the range of the standard
curve. For samples with consistent results, the mean value of the
three replicates was taken to represent the copies of bacterial
rRNA genes present in the sample. If all three replicates were not-
detected, then the quantity of bacteria present was assumed to be
below the limit of detection. Inconsistent results were examined in
more detail and in most cases the result was determined using a set
of quality control rules as follows: (1) if two values were not-
detected and the third value was ,10 copies/reaction, then the
sample value equaled the detected value, and (2) if two non-
missing values were within 0.2 log, with the third value being
either missing or different by more than 0.2 log, then the sample
value equaled the mean of two values. Assays that did not meet
these criteria were considered unacceptable and qPCR reactions
were rerun.
(TIF)
Figure S2 ANOVA analysis of total precision with
between-run and within-run comparisons. Subject was
the primary factor contributing to differences in measurement
across plates and across wells (n=24 samples). Five factors and six
pairwise interactions were analyzed. There was greater variability
across subjects for P. melaninogenica than for bacterial load assay.
(TIF)
Figure S3 Sensitivity of S. aureus qPCR assay is highest
for samples with quantities of S. aureus $10
5 cfu/ml by
culture (n=49 specimens).
(TIF)
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